Description
Enoxacinisafluoroquinoloneantibioticthatisclinicallyusedtotreaturinarytractinfectionsandgonorrhea;likeotherfluoroquinolones,enoxacininhibitsDNAgyraseandtopoisomeraseIV.Enoxacindisplaysantibacterialandanti-resorptiveactivities.Invivo,thiscompounddecreasesRANKL-inducedJNKsignaling,inhibitingosteoclastformation.Additionally,enoxacininhibitsvacuolarH+ATPaseactivity,preventingboneresorption.
References
LiuX,QuX,WuC,etal.Theeffectofenoxacinonosteoclastogenesisandreductionoftitaniumparticle-inducedosteolysisviasuppressionofJNKsignalingpathway.Biomaterials.2014Jul;35(22):5721-30.PMID:24767789.
ToroEJ,ZuoJ,OstrovDA,etal.Enoxacindirectlyinhibitsosteoclastogenesiswithoutinducingapoptosis.JBiolChem.2012May18;287(21):17894-904.PMID:22474295.
ZumaAA,CavalcantiDP,MaiaMC,etal.EffectoftopoisomeraseinhibitorsandDNA-bindingdrugsonthecellproliferationandultrastructureofTrypanosomacruzi.IntJAntimicrobAgents.2011May;37(5):449-56.PMID:21292448.
KosekiN,DeguchiJ,YamashitaA,etal.Establishmentfoanovelexperimentalprotocolfordrug-inducedseizureliABIlityscreeningbasedonalocomotoractivityassayinzebrafish.JToxicolSci.2014Aug;39(4):579-600.PMID:25056783.